| NeuroX1 |
Competitors |
|
- Valence
- Covalent Technologies
|
Approved |
| NeuroX1 |
Twitter |
|
neurox_1 |
Approved |
| NeuroX1 |
Benefits |
|
Increase the speed and specificity of drug discovery through the use of generative chemistry. |
Approved |
| NeuroX1 |
Problem Solving |
|
Accelerating the discovery of novel neurotherapeutics |
Historical |
| NeuroX1 |
URL |
|
www.neurox1.com |
Approved |
| NeuroX1 |
LinkedIn |
|
neurox1 |
Approved |
| NeuroX1 |
CrunchBase |
|
neurox1/signals_and_news |
Approved |
| NeuroX1 |
Logo |
|
 |
Historical |
| NeuroX1 |
Contact E-mail |
|
[email protected] |
Approved |
| NeuroX1 |
Contact Phone |
|
512-270-3958 |
Historical |
| NeuroX1 |
Tags |
|
- Biotechnology
- Life Science
- Artificial Intelligence
- AI
- Drug
- Pharmaceutical
- Pharmaceuticals
|
Approved |
| NeuroX1 |
City |
|
Austin |
Approved |
| NeuroX1 |
State |
|
Texas |
Approved |
| NeuroX1 |
Type |
|
Startup |
Approved |
| NeuroX1 |
Business Type |
|
B2B (Business to Business) |
Approved |
| NeuroX1 |
Business Model Type |
|
Licensing |
Approved |
| NeuroX1 |
Industry |
|
Pharmaceuticals & Biotechnology |
Approved |
| NeuroX1 |
State Status |
|
Private Beta |
Approved |
| NeuroX1 |
Employees Number |
|
6 - 10 |
Approved |
| NeuroX1 |
Name |
|
NeuroX1 |
Approved |
| NeuroX1 |
Legal Name |
|
NeuroX1 Inc. |
Approved |
| NeuroX1 |
Phrase |
|
The new standard in computational neuroscience |
Approved |
| NeuroX1 |
Country |
|
United States |
Approved |
| NeuroX1 |
Postal Code |
|
78705 |
Approved |
| NeuroX1 |
Target Customer |
|
Pharmaceutical Companies |
Approved |
| NeuroX1 |
Description |
|
NeuroX1 is a computational drug design company building a platform to better understand degenerative disorders of the brain.
Computational drug discovery using AI/ML to create therapeutics for neurodegenerative disorders. |
Historical |
| NeuroX1 |
Date Founded |
|
2021-11-18 |
Approved |
